Stephen P. Squinto, EVP, Head of R&D at ALEXION PHARMACEUTICALS INC (ALXN), sold 20,000 shares at $91.21 ($1.8M) on 2013-03-08, disclosed to the SEC on 2013-03-12.
Seasonal sale ($1.8M) by EVP, Head of R&D — this insider has traded ALXN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.21 | 16,915 | $1.5M | 84.4% |
| 2 | $92.17 | 3,085 | $284K | 15.6% |
| Total | $91.36 avg | 20,000 | $1.8M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |